Complete Filing Data
NP Life Sciences Health Industry Group Inc. reported Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations of $70.6 thousand for FY2023.
All values from 10-K, 20-F, and 10-Q filings on SEC EDGAR, organized by financial statement. Scroll each table horizontally for the full history. Blank cells mean NP Life Sciences Health Industry Group Inc. did not report that metric for that period in XBRL — often because accounting standards changed which tag a company files under (for example, most companies moved revenue to the ASC-606 tag in 2018), so a metric may continue in a different row. Rows marked * merge those successor tags into one continuous series, preferring the audited value from the newest-standard tag where periods overlap.
Income Statement
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 |
|---|---|---|---|---|---|---|
| Net Income * | -$2.9K | -$18.9K | -$65.7K | -$131.1K | -$108.8K | -$20.9K |
| Operating Income Loss | -$690.00 | -$18.9K | -$65.7K | -$131.1K | -$108.9K | -$20.9K |
| General And Administrative Expense | $165.3K | $120.9K | $100.7K | $146.1K | $151.9K | $20.9K |
| Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest | -$1.3K | -$18.9K | -$65.7K | -$131.1K | -$108.8K | -$20.9K |
| Nonoperating Income Expense | -$1.00 | $4.00 | ||||
| Revenue From Contract With Customer Excluding Assessed Tax | $164.6K | $102.0K | $35.0K | $15.0K | $43.0K | |
| Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest | -$2.9K | -$18.9K | -$65.7K | -$131.1K | ||
| Other Comprehensive Income Loss Net Of Tax | -$131.1K | -$108.8K | -$20.9K | |||
| Other Nonoperating Income Expense | ||||||
| Income Loss From Continuing Operations Before Income Taxes | -$18.9K | -$65.7K | ||||
| Discontinued Operation Income Loss From Discontinued Operation Before Income Tax | ||||||
| Interest Income Expense Net | -$1.00 | $4.00 | ||||
| Income Tax Expense Benefit | $1.6K | |||||
| Interest Expense | $645.00 | $1.00 | ||||
| Income Taxes Paid Net | $1.6K | |||||
| Impairment Of Intangible Assets Finitelived | $5.6K |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 | Q3 2021 | Q2 2021 | Q1 2021 | Q3 2020 | Q2 2020 | Q1 2020 | Q3 2019 | Q2 2019 | Q1 2019 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Income * | -$37.7K | $71.2K | $1.2K | -$5.4K | $1.1K | -$31.1K | -$20.8K | -$52.7K | -$24.2K | -$25.6K | -$53.7K | -$30.1K | -$31.9K | -$5.0K | -$29.7K |
| Operating Income Loss | -$37.4K | $71.4K | $1.2K | -$5.4K | $1.1K | -$31.1K | -$20.8K | -$52.7K | -$24.2K | -$25.6K | -$53.7K | -$30.1K | -$31.9K | -$4.7K | -$29.7K |
| General And Administrative Expense | $55.0K | $35.7K | $28.8K | $46.4K | $13.9K | $31.1K | $20.8K | $52.7K | $24.2K | $25.6K | $53.7K | $45.1K | $31.9K | $27.7K | $49.7K |
| Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest | -$37.4K | $1.2K | -$5.4K | $1.1K | -$31.1K | -$20.8K | -$52.7K | -$24.2K | -$25.6K | -$53.7K | -$30.1K | -$31.9K | -$4.7K | -$29.7K | |
| Nonoperating Income Expense | -$225.00 | -$197.00 | -$3.00 | $1.00 | $1.00 | $1.00 | $2.00 | $4.00 | $9.00 | $11.00 | $13.00 | -$292.00 | $1.00 | ||
| Revenue From Contract With Customer Excluding Assessed Tax | $17.5K | $107.1K | $30.0K | $41.0K | $15.0K | $0.00 | $15.0K | $23.0K | $20.0K | ||||||
| Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest | -$37.7K | $71.2K | $1.2K | -$5.4K | $1.1K | -$31.1K | -$20.8K | -$52.7K | -$24.2K | -$25.6K | |||||
| Other Comprehensive Income Loss Net Of Tax | -$52.7K | -$24.2K | -$25.6K | -$53.7K | -$30.1K | -$31.9K | -$5.0K | -$29.7K | |||||||
| Other Nonoperating Income Expense | -$225.00 | -$197.00 | -$1.00 | -$298.00 | |||||||||||
| Income Loss From Continuing Operations Before Income Taxes | $71.4K | $1.2K | $1.1K | -$31.1K | |||||||||||
| Discontinued Operation Income Loss From Discontinued Operation Before Income Tax | -$37.7K | -$5.4K | |||||||||||||
| Interest Income Expense Net | -$3.00 | ||||||||||||||
| Income Tax Expense Benefit | |||||||||||||||
| Interest Expense | |||||||||||||||
| Income Taxes Paid Net | |||||||||||||||
| Impairment Of Intangible Assets Finitelived |
Balance Sheet
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 |
|---|---|---|---|---|---|---|
| Stockholders Equity * | $16.4K | $19.3K | $38.2K | $103.8K | $234.9K | -$20.7K |
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations | $70.6K | $121.9K | $28.0K | $118.6K | $242.9K | $200.00 |
| Retained Earnings Accumulated Deficit | -$348.2K | -$345.3K | -$326.5K | -$260.8K | -$129.7K | -$20.9K |
| Liabilities And Stockholders Equity | $76.9K | $127.8K | $38.4K | $118.6K | $250.1K | $200.00 |
| Liabilities | $60.5K | $108.5K | $239.00 | $14.8K | $15.2K | $20.9K |
| Common Stock Value | $4.3K | $4.3K | $4.3K | $4.3K | $4.4K | $7.00 |
| Cash And Cash Equivalents At Carrying Value | $70.6K | $121.9K | $28.0K | $118.6K | $242.9K | $200.00 |
| Assets | $76.9K | $127.8K | $38.4K | $118.6K | $250.1K | $200.00 |
| Accrued Liabilities Current | $25.1K | $2.5K | $239.00 | $14.8K | $14.2K | $20.4K |
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect | -$51.2K | $93.9K | -$90.6K | -$124.3K | $242.7K | $200.00 |
| Accounts Payable Current | $6.1K | $6.1K | $1.0K | $466.00 | ||
| Intangible Assets Net Excluding Goodwill | $7.2K | |||||
| Contract With Customer Liability Current | $99.6K | |||||
| Other Notes Payable Current | $6.9K | $239.00 | ||||
| Taxes Payable Current | ||||||
| Liabilities Current | $38.1K | $108.5K | ||||
| Assets Current | ||||||
| Additional Paid In Capital Common Stock | ||||||
| Liabilities Noncurrent | $22.4K |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 | Q3 2020 | Q2 2020 | Q1 2020 | Q3 2019 | Q2 2019 | Q1 2019 | Q4 2018 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Stockholders Equity * | $31.7K | $67.1K | $20.5K | $19.3K | $2.7K | $8.2K | $7.1K | $38.2K | $5.9K | $26.9K | $79.6K | $125.5K | $151.1K | $204.8K | $277.2K | |||
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations | $84.6K | $125.1K | $140.1K | $7.0K | $575.00 | $23.1K | $25.0K | $40.7K | $89.4K | $145.0K | $168.5K | $222.2K | $276.6K | $281.8K | $45.1K | |||
| Retained Earnings Accumulated Deficit | -$332.9K | -$297.5K | -$344.1K | -$361.9K | -$356.5K | -$357.5K | -$358.7K | -$337.8K | -$285.0K | -$239.1K | -$213.5K | -$159.8K | -$87.4K | |||||
| Liabilities And Stockholders Equity | $95.3K | $144.1K | $142.4K | $16.9K | $17.0K | $24.8K | $25.0K | $40.7K | $89.9K | $151.4K | $175.3K | $228.9K | $286.2K | |||||
| Liabilities | $63.6K | $77.0K | $121.9K | $14.2K | $8.9K | $17.7K | $19.1K | $13.9K | $10.3K | $25.9K | $24.2K | $24.2K | $8.9K | |||||
| Common Stock Value | $4.3K | $4.3K | $4.3K | $4.3K | $4.3K | $4.3K | $4.3K | $4.3K | $4.3K | $4.3K | $4.3K | $4.3K | $4.3K | |||||
| Cash And Cash Equivalents At Carrying Value | $84.6K | $125.1K | $140.1K | $7.0K | $575.00 | $23.1K | $25.0K | $40.7K | $89.4K | $145.0K | $168.5K | $222.2K | $276.6K | |||||
| Assets | $95.3K | $144.1K | $142.4K | $16.9K | $17.0K | $24.8K | $25.0K | $40.7K | $89.9K | $151.4K | $175.3K | $228.9K | $286.2K | |||||
| Accrued Liabilities Current | $3.4K | $3.2K | $3.2K | $5.0K | $5.0K | $2.7K | $19.1K | $13.9K | $10.3K | $22.6K | $20.9K | $20.9K | $5.4K | |||||
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect | $18.2K | -$4.9K | -$29.2K | -$20.7K | $44.9K | |||||||||||||
| Accounts Payable Current | $6.0K | $6.0K | $6.0K | $9.2K | $3.9K | $3.3K | $3.3K | $3.3K | $3.5K | |||||||||
| Intangible Assets Net Excluding Goodwill | $6.4K | $6.8K | $6.7K | $7.6K | ||||||||||||||
| Contract With Customer Liability Current | $10.0K | $7.5K | $112.6K | $15.0K | ||||||||||||||
| Other Notes Payable Current | $239.00 | $13.3K | ||||||||||||||||
| Taxes Payable Current | $21.5K | $24.6K | ||||||||||||||||
| Liabilities Current | ||||||||||||||||||
| Assets Current | $278.5K | $200.00 | ||||||||||||||||
| Additional Paid In Capital Common Stock | $360.3K | $193.00 | ||||||||||||||||
| Liabilities Noncurrent |
Cash Flow Statement
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 |
|---|---|---|---|---|---|---|
| Net Cash Provided By Used In Operating Activities | -$73.6K | $93.9K | -$90.6K | -$124.3K | -$4.3K | $0.00 |
| Increase Decrease In Accrued Liabilities | $22.6K | $2.5K | -$14.5K | $610.00 | -$6.3K | $20.4K |
| Increase Decrease In Prepaid Expense | $325.00 | -$4.5K | $10.4K | |||
| Increase Decrease In Accounts Payable | $6.1K | -$1.0K | $565.00 | $466.00 | ||
| Net Cash Provided By Used In Financing Activities | $22.4K | $364.4K | $200.00 | |||
| Increase Decrease In Contract With Customer Liability | -$99.6K | $99.6K | ||||
| Payments To Acquire Intangible Assets | $8.6K | |||||
| Net Cash Provided By Used In Investing Activities | -$8.6K | |||||
| Proceeds From Issuance Or Sale Of Equity | $364.4K | $200.00 | ||||
| Increase Decrease In Other Accounts Payable And Accrued Liabilities | $6.7K | |||||
| Increase Decrease In Accounts Receivable | ||||||
| Proceeds From Issuance Of Long Term Debt | $22.4K |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q1 2023 | Q1 2022 | Q1 2021 | Q1 2020 | Q1 2019 |
|---|---|---|---|---|---|
| Net Cash Provided By Used In Operating Activities | $18.2K | -$4.9K | -$29.2K | -$20.7K | -$52.1K |
| Increase Decrease In Accrued Liabilities | $500.00 | $2.5K | -$4.4K | $9.0K | -$12.0K |
| Increase Decrease In Prepaid Expense | -$3.6K | -$8.7K | $513.00 | $451.00 | |
| Increase Decrease In Accounts Payable | -$105.00 | $9.8K | |||
| Net Cash Provided By Used In Financing Activities | $104.3K | ||||
| Increase Decrease In Contract With Customer Liability | $13.0K | $15.0K | |||
| Payments To Acquire Intangible Assets | $7.3K | ||||
| Net Cash Provided By Used In Investing Activities | -$7.3K | ||||
| Proceeds From Issuance Or Sale Of Equity | $104.3K | ||||
| Increase Decrease In Other Accounts Payable And Accrued Liabilities | |||||
| Increase Decrease In Accounts Receivable | $20.0K | ||||
| Proceeds From Issuance Of Long Term Debt |
Per-Share & Share Counts
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 |
|---|---|---|---|---|---|---|
| Diluted EPS * | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | -$0.58 |
| Preferred Stock Shares Authorized | 30.0M | 30.0M | 30.0M | 30.0M | 30.0M | 30.0M |
| Preferred Stock Par Or Stated Value Per Share | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Common Stock Shares Outstanding | 43.0M | 43.0M | 43.0M | 43.0M | 43.0M | 66.7K |
| Common Stock Shares Issued | 43.0M | 43.0M | 43.0M | 43.0M | 43.0M | 66.7K |
| Common Stock Shares Authorized | 320.0M | 320.0M | 320.0M | 320.0M | 320.0M | 320.0M |
| Common Stock Par Or Stated Value Per Share | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Preferred Stock Shares Outstanding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Preferred Stock Shares Issued | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Weighted Average Number Of Share Outstanding Basic And Diluted | 43.0M | 43.0M | 34.1M | 35.9K | ||
| Weighted Average Number Of Shares Outstanding Basic | 43.0M | 43.0M | 43.0M | |||
| Weighted Average Number Of Diluted Shares Outstanding | 43.0M | 43.0M | ||||
| Earnings Per Share Basic | $0.00 | $0.00 |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 | Q3 2021 | Q2 2021 | Q1 2021 | Q3 2020 | Q2 2020 | Q1 2020 | Q3 2019 | Q2 2019 | Q1 2019 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Diluted EPS * | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | ||||||
| Preferred Stock Shares Authorized | 30.0M | 30.0M | 30.0M | 30.0M | 30.0M | 30.0M | 30.0M | 30.0M | 30.0M | 30.0M | 30.0M | 30.0M | 30.0M | ||
| Preferred Stock Par Or Stated Value Per Share | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | ||
| Common Stock Shares Outstanding | 43.0M | 43.0M | 43.0M | 43.0M | 43.0M | 43.0M | 43.0M | 43.0M | 43.0M | 43.0M | 43.0M | 43.0M | 43.0M | ||
| Common Stock Shares Issued | 43.0M | 43.0M | 43.0M | 43.0M | 43.0M | 43.0M | 43.0M | 43.0M | 43.0M | 43.0M | 43.0M | 43.0M | 43.0M | ||
| Common Stock Shares Authorized | 320.0M | 320.0M | 320.0M | 320.0M | 320.0M | 320.0M | 320.0M | 320.0M | 320.0M | 320.0M | 320.0M | 320.0M | 320.0M | ||
| Common Stock Par Or Stated Value Per Share | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | ||
| Preferred Stock Shares Outstanding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Preferred Stock Shares Issued | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Weighted Average Number Of Share Outstanding Basic And Diluted | 43.0M | 43.0M | 43.0M | 43.0M | 43.0M | 43.0M | 43.0M | 37.4M | 12.9M | ||||||
| Weighted Average Number Of Shares Outstanding Basic | 43.0M | 43.0M | 43.0M | 43.0M | 43.0M | 43.0M | 43.0M | 43.0M | 43.0M | ||||||
| Weighted Average Number Of Diluted Shares Outstanding | 43.0M | 43.0M | 43.0M | 43.0M | |||||||||||
| Earnings Per Share Basic | $0.00 | $0.00 | $0.00 |
Other Metrics
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 |
|---|---|---|---|---|---|---|
| Interest Income Other | $4.00 | $26.00 | $32.00 | |||
| Additional Paid In Capital | $360.3K | $360.3K | $360.3K | $360.3K | $360.3K | $193.00 |
| Prepaid Expense Current | $6.3K | $5.9K | $10.4K | |||
| Adjustment For Amortization | $1.6K | $1.4K | ||||
| Stock Issued During Period Value New Issues | $364.4K | $200.00 | ||||
| Interest Received Net | $4.00 | $26.00 | $32.00 | |||
| Interest Paid Net | $1.00 |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 | Q3 2021 | Q2 2021 | Q1 2021 | Q3 2020 | Q2 2020 | Q1 2020 | Q3 2019 | Q2 2019 | Q1 2019 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Interest Income Other | $1.00 | $1.00 | $1.00 | $2.00 | $4.00 | $9.00 | $11.00 | $13.00 | $6.00 | $1.00 | |||||
| Additional Paid In Capital | $360.3K | $360.3K | $360.3K | $360.3K | $360.3K | $360.3K | $360.3K | $360.3K | $360.3K | $360.3K | $360.3K | $360.3K | |||
| Prepaid Expense Current | $10.8K | $19.0K | $2.4K | $10.0K | $16.5K | $1.7K | $513.00 | $1.9K | |||||||
| Adjustment For Amortization | $444.00 | $209.00 | |||||||||||||
| Stock Issued During Period Value New Issues | |||||||||||||||
| Interest Received Net | |||||||||||||||
| Interest Paid Net |
Most recent annual filing with the SEC: April 16, 2024
Data sourced from SEC EDGAR public filings as of August 4, 2026.